- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Robert M. Cooper (Bob)
News 21 results
In the News · Source: Global Competition Review
In the News · Source: Law360
June 29, 2026
K&S counsels Novo Nordisk before a New York federal court in a class action antitrust dispute
In the News · Source: The National Law Journal
February 20, 2026
Bob Cooper discusses the FTC officially rescinding its rule limiting noncompete agreements
In the News · Source: Law360
February 17, 2026
Bob Cooper comments on the decision made by a Texas federal court to throw out the FTC's premerger rule
Events 8 results
Conference
January 28, 2026
Healthcare Deal Summit
Conference
October 15, 2025
Health Law & Policy Forum West
Conference
September 4, 2025
18th Annual King & Spalding Medical Device Summit
Conference
March 17, 2025
34th Annual King & Spalding Health Law & Policy Forum
Insights 18 results
Client Alert
July 27, 2026
The Department of Justice Announces “Targeted” and “Expedited” Merger Investigations
Client Alert
March 3, 2026
COPPA Meets Reality: The FTC Signals a New Approach to Age Verification
Client Alert
February 13, 2026
New HSR Rules Struck Down
Client Alert
January 15, 2026
FTC Announces 2026 Jurisdictional Threshold Updates for Interlocking Directorates and HSR Filing Thresholds